Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19198041 | 0.94 | MEN1 (0.31) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL19198023 | 0.94 | MEN1 (0.31) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL19196972 | 0.93 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL19197339 | 0.93 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL19197117 | 0.91 | MEN1 (0.30) | MEN1KMT2A | |
| SCHEMBL19198022 | 0.90 | SOS1 (0.32) | MAPT | |
| SCHEMBL19197384 | 0.89 | PDK2 (0.32) | — | |
| SCHEMBL19197115 | 0.89 | SOS1 (0.31) | — | |
| SCHEMBL19197421 | 0.89 | — | — | |
| SCHEMBL13055892 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10547007-B2 | Compound, organic electroluminescent material, organic electroluminescent element, and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2020-01-28 | — | — | US | disclosed |
| US-20170222144-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20170222144-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10547007-B2 | Compound, organic electroluminescent material, organic electroluminescent element, and electronic apparatus | RPS10, RPS20, RPS19 | MEN1 966/4885KMT2A 1804/4885KDM4E 2027/4885 |
| US-20170222144-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPARATUS | RPS10, RPS20, RPS19 | MEN1 966/4885KMT2A 1804/4885KDM4E 2027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.